AMAZON, RESEARCHERS PARTNER

Amazon will collaborate with the Fred Hutchinson Cancer Center in Seattle on a Food and Drug Administration-approved clinical trial for a cancer vaccine.

According to a filing with the National Institutes of Health, Fred Hutch is testing a “personalized” vaccine for patients with late-stage melanoma skin cancer and certain breast cancers that have spread throughout the body or are not responding to other treatment.

Fred Hutch is listed as the trial’s sponsor, and Amazon as the sole collaborator. The duo set a recruitment target of 20 participants above 18 years of age with skin and breast cancers for its phase one trial.